Los Angeles Capital Management
HAE icon

Los Angeles Capital Management’s Haemonetics HAE Stock Holding History

Los Angeles Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.1K Hold
250
– – ﹤0.01% 1852
2025
Q4 		$12.5K Buy
+250
New +$16.8K ﹤0.01% 2010
2025
Q1 		– Sell
-16,415
Closed -$1.28M – 1137
2024
Q4 		$1.28M Sell
16,415
-7,539
-31% -$606K 0.01% 548
2024
Q3 		$1.93M Sell
23,954
-200
-0.8% -$16.2K 0.01% 471
2024
Q2 		$2M Sell
24,154
-2,761
-10% -$243K 0.01% 456
2024
Q1 		$2.3M Buy
26,915
+1,277
+5% +$100K 0.01% 464
2023
Q4 		$2.19M Sell
25,638
-27,420
-52% -$2.37M 0.01% 458
2023
Q3 		$4.75M Buy
53,058
+586
+1% +$52.3K 0.02% 321
2023
Q2 		$4.47M Buy
52,472
+6,298
+14% +$532K 0.02% 347
2023
Q1 		$3.82M Buy
46,174
+38,685
+517% +$3.13M 0.02% 385
2022
Q4 		$589K Buy
+7,489
New +$602K ﹤0.01% 848
2021
Q3 		– Sell
-7,349
Closed -$490K – 1528
2021
Q2 		$490K Buy
7,349
+334
+5% +$23.6K ﹤0.01% 1171
2021
Q1 		$779K Hold
7,015
– – ﹤0.01% 1020
2020
Q4 		$833K Sell
7,015
-3,490
-33% -$376K ﹤0.01% 1013
2020
Q3 		$917K Sell
10,505
-20,641
-66% -$1.8M ﹤0.01% 854
2020
Q2 		$2.79M Sell
31,146
-2,513
-7% -$254K 0.01% 526
2020
Q1 		$3.35M Buy
33,659
+25
+0.1% +$2.71K 0.02% 415
2019
Q4 		$3.87M Sell
33,634
-2,711
-7% -$328K 0.02% 478
2019
Q3 		$4.58M Sell
36,345
-8,193
-18% -$1.04M 0.02% 433
2019
Q2 		$5.36M Sell
44,538
-6,740
-13% -$663K 0.03% 427
2019
Q1 		$4.49M Sell
51,278
-3,220
-6% -$293K 0.02% 454
2018
Q4 		$5.45M Sell
54,498
-730
-1% -$76.7K 0.03% 361
2018
Q3 		$6.33M Sell
55,228
-4,165
-7% -$431K 0.03% 417
2018
Q2 		$5.33M Buy
59,393
+7,043
+13% +$595K 0.03% 468
2018
Q1 		$3.83M Buy
52,350
+630
+1% +$43.2K 0.02% 478
2017
Q4 		$3M Sell
51,720
-25,849
-33% -$1.36M 0.02% 553
2017
Q3 		$3.48M Buy
77,569
+23,680
+44% +$984K 0.02% 499
2017
Q2 		$2.13M Buy
53,889
+37,160
+222% +$1.53M 0.01% 596
2017
Q1 		$679K Sell
16,729
-3,124
-16% -$122K ﹤0.01% 817
2016
Q4 		$798K Sell
19,853
-13,665
-41% -$515K 0.01% 756
2016
Q3 		$1.21M Buy
33,518
+815
+2% +$28K 0.01% 679
2016
Q2 		$948K Buy
+32,703
New +$988K 0.01% 713
2014
Q3 		– Sell
-36,855
Closed -$1.3M – 1111
2014
Q2 		$1.3M Buy
36,855
+5,095
+16% +$170K 0.01% 606
2014
Q1 		$1.03M Sell
31,760
-25,055
-44% -$958K 0.01% 662
2013
Q4 		$2.39M Buy
56,815
+10,670
+23% +$439K 0.03% 468
2013
Q3 		$1.84M Buy
46,145
+8,535
+23% +$358K 0.02% 492
2013
Q2 		$1.55M Buy
+37,610
New +$1.52M 0.02% 522

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Los Angeles Capital Management's HAE Position: Q1 2026 in Review

Los Angeles Capital Management held its Haemonetics (HAE) position steady in Q1 2026 at 250 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Los Angeles Capital Management first reported a position in HAE in Q2 2013 and has held it in 37 quarters since. The position peaked at $6.33M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Los Angeles Capital Management held 250 shares of Haemonetics worth $14.1K as of Q1 2026.
  • Los Angeles Capital Management left its Haemonetics share count unchanged in Q1 2026.
  • Haemonetics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1852 holding.
  • Los Angeles Capital Management first reported a position in Haemonetics in Q2 2013 and has held it in 37 quarters since.
  • Los Angeles Capital Management's Haemonetics position peaked at $6.33M in Q3 2018.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.